查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1529619

基於水凝膠的 DDS（藥物傳輸系統）市場規模、佔有率和趨勢分析報告：按聚合物來源、傳輸途徑、地區和細分市場預測，2024-2030 年

Hydrogel-based Drug Delivery System Market Size, Share & Trends Analysis Report By Polymer Origin (Natural, Synthetic, Hybrid), By Delivery Route, By Region, And Segment Forecast, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

基於水凝膠的 DDS（藥物傳輸系統）市場成長與趨勢：

Grand View Research最新報告顯示，到2030年，全球水凝膠DDS市場規模預計將達到117.7億美元。

預計2024年至2030年該市場將以6.7%的複合年成長率擴張。水凝膠有助於在空間和時間上控制所摻入藥物的釋放。因此，許多治療領域對控制釋放藥物輸送系統的需求迅速成長是預測期內推動市場成長的主要因素。

以水凝膠為基礎的 DDS 將治療劑直接且永續地遞送至目標部位。這可以帶來有益的結果，例如提高療效、減少副作用以及減少患者和藥物製造商的劑量。基於水凝膠的 DDS 很有吸引力，可用於許多醫學領域，包括腫瘤學、疼痛管理、免疫學、心臟病學和傷口管理。

水凝膠獨特的物理性質引起了人們對其在藥物傳輸方面的應用的興趣。水凝膠的孔隙率和載藥能力可以透過調節交聯密度來調節。這有助於保護大藥物分子免於分解，並延長半衰期。已經對使用水凝膠系統口服胰島素進行了許多研究。此類創新預計將成為糖尿病治療市場的顛覆性技術，因為注射胰島素經常出現患者依從性問題。

針對基於水凝膠的 DDS 的大量臨床研究正在進行中，並且各種水凝膠技術已獲得生物醫學應用的監管核准。然而，缺乏明確的監管指南、化學問題、複雜的製造和控制參數以及實際適應性等技術挑戰仍然是成功給藥的主要障礙。例如，水凝膠的生產很複雜，並且根據水凝膠系統的不同而有很大差異。

基於水凝膠的 DDS 市場報告亮點：

  • 根據聚合物來源，合成細分市場在 2023 年佔據最大市場佔有率。
  • 由於刺激響應水凝膠技術的發展，預計混合市場將在預測期內呈現最快的成長率。
  • 與天然水凝膠相比，合成水凝膠由於其高載藥量和改進的機械強度，預計在預測期內將出現快速成長。
  • 根據交付路線，眼部細分市場在 2023 年佔據最大的收益佔有率。
  • 由於正在進行的臨床和臨床前試驗數量不斷增加，預計皮下細分市場將在預測期內實現健康成長。
  • 由於北美地區有主要企業在研究和開發基於水凝膠的特定 DDS，因此北美地區佔據了該市場的最大收益佔有率。
  • 由於患者人數眾多、醫療基礎設施改善以及對尖端治療的需求激增，預計亞太地區在預測期內將以最快的速度成長市場。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章基於水凝膠的 DDS 市場變數、趨勢和範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 基於水凝膠的 DDS 市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 基於水凝膠的DDS市場：基於聚合物的估算與趨勢分析

  • 細分儀表板
  • 基於水凝膠的 DDS 市場：2023 年和 2030 年聚合物衍生波動分析
  • 自然
  • 合成
  • 混合

第5章 基於水凝膠的 DDS 市場：遞送路線估計和趨勢分析

  • 細分儀表板
  • 基於水凝膠的 DDS 市場：2023 年和 2030 年輸送路線波動分析
  • 皮下的
  • 眼睛
  • 口腔
  • 局部的
  • 其他

第6章基於水凝膠的DDS市場：區域估計和趨勢分析

  • 2023 年和 2030 年按地區分類的水凝膠 DDS市場佔有率，十億美元
  • 北美洲
    • 2018-2030 年北美基於水凝膠的 DDS 市場估計與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 2018-2030 年歐洲基於水凝膠的 DDS 市場估計與預測
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 亞太地區基於水凝膠的 DDS 市場估計和預測，2018-2030 年
    • 中國
    • 日本
    • 印度
    • 韓國
  • 拉丁美洲
    • 拉丁美洲基於水凝膠的 DDS 市場估計和預測，2018-2030 年
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 2018-2030 年中東和非洲基於水凝膠的 DDS 市場估計和預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 南非

第7章 競爭格局

  • 主要市場參與企業的最新趨勢和影響分析
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • GE HealthCare
    • Siemens Healthineers AG
    • Medtronic
    • Aramark
    • Koninklijke Philips NV
    • B. Braun SE
    • AlphaSource Group
    • Althea Group
簡介目錄
Product Code: GVR-4-68038-285-3

Hydrogel-based Drug Delivery System Market Growth & Trends:

The global hydrogel-based drug delivery system market size is anticipated to reach USD 11.77 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.7% from 2024 to 2030. Hydrogels help in achieving spatial and temporal control over the release of the incorporated drug. Therefore, the surging demand for controlled releases drug delivery system across many therapeutic areas is a key factor expected to contribute to market growth during the forecast period.

Hydrogel-based drug delivery systems deliver the therapeutic drug directly at the target site and in a sustained manner. This can leverage beneficial outcomes such as improved efficacy, reduced side effects, and decreased dosage for patients and formulators. Hydrogel-based drug delivery systems are appealing and have been used in many branches of medicine such as oncology, pain management, immunology, cardiology, and wound management.

The unique physical properties of hydrogel attract their interest in use for drug delivery applications. The porosity and drug loading capacity of hydrogels can be adjusted by modifying the density of cross-linking. This helps them to protect liable large drug molecules from degradation increasing the half-life. Many research studies have been carried out to examining the delivery of insulin orally using hydrogel systems. As patient compliance issues are frequently reported with injectable insulins such innovation is expected to be a disruptive technology in the diabetes care market.

There are numerous clinical studies underway specific to hydrogel-based drug delivery systems and various hydrogel technologies have already received regulatory approval for biomedical application. However, the technological challenges including the absence of defined regulatory guidelines, chemistry, complex manufacturing and control paraments, and practical adaptability are major roadblocks in the successful implementation in drug delivery use. For instance, the fabrication of hydrogel is complex and varies significantly depending upon the hydrogel systems.

Hydrogel-based Drug Delivery System Market Report Highlights:

  • Based on polymer origin, the synthetic segment held the largest proportion of market share in 2023
  • The hybrid segment is expected to witness the fastest growth rate over the forecast period owing to the development of stimuli-responsive hydrogel technology
  • The synthetic segment is anticipated to grow fast over the forecast period compared to natural hydrogels due to their high drug loading capacity and improved mechanical strength
  • Based on delivery route, the ocular segment accounted for the largest revenue share in 2023
  • The subcutaneous segment is expected to grow at a healthy rate over the forecast period owing to the increasing number of clinical and pre-clinical studies carried out
  • North America holds the largest revenue share in this market due to the presence of key companies in the region doing R&D on specific hydrogel-based drug delivery systems
  • In Asia Pacific, the market is expected to grow at the fastest rate over the forecast period due to large patient base, improving healthcare infrastructure, and surging demand for modern therapies

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Hydrogel-based Drug Delivery System Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Hydrogel-based Drug Delivery System Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Hydrogel-based Drug Delivery System Market: Polymer Origin Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Hydrogel-based Drug Delivery System Market: Polymer Origin Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Natural
    • 4.3.1. Natural Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Synthetic
    • 4.4.1. Synthetic Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Hybrid
    • 4.5.1. Hybrid Polymer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Hydrogel-based Drug Delivery System Market: Delivery Route Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Hydrogel-based Drug Delivery System Market: Delivery Route Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Subcutaneous
    • 5.3.1. Subcutaneous delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Ocular
    • 5.4.1. Ocular delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Oral Cavity
    • 5.5.1. Oral Cavity delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Topical
    • 5.6.1. Topical delivery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Other delivery routes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Hydrogel-based Drug Delivery System Market: Regional Estimates & Trend Analysis

  • 6.1. Hydrogel-based Drug Delivery System Market Share, By Region, 2023 & 2030, USD Billion
  • 6.2. North America
    • 6.2.1. North America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. China
      • 6.4.2.1. China Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Japan
      • 6.4.3.1. Japan Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. South Korea
      • 6.4.5.1. South Korea Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Saudi Arabia Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. UAE Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Kuwait Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Africa
      • 6.6.5.1. South Africa Hydrogel-based Drug Delivery System Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. GE HealthCare
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Siemens Healthineers AG
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Medtronic
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Aramark
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Koninklijke Philips N.V.
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. B. Braun SE
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. AlphaSource Group
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Althea Group
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives